Mathematical modelling of radiotherapy strategies for early breast cancer

Journal of Theoretical Biology

Volumn 241, Issue 1, 2006, Pages 158-171

  Enderling, Heiko ^a   Anderson, Alexander R A ^a   Chaplain, Mark A J ^a   Munro, Alastair J ^b   Vaidya, Jayant S ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Breast cancer; Intraoperative radiotherapy; Local recurrence; Mathematical modelling; Radiotherapy; Targit; Tumour invasion

Indexed keywords

DNA; GENE; HETEROZYGOSITY; IRRADIATION; MUTATION; TUMOR;

ARTICLE; BREAST CANCER; CANCER INVASION; CELL STRUCTURE; CELL SURVIVAL; DISEASE PREDISPOSITION; DNA DAMAGE; HETEROZYGOSITY; MATHEMATICAL MODEL; PRIORITY JOURNAL; RADIATION DOSE; TUMOR CELL; TUMOR GROWTH; TUMOR RECURRENCE;

BRACHYTHERAPY; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MASTECTOMY, SEGMENTAL; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MUTAGENESIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT;

EID: 33744512046     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2005.11.015     Document Type: Article

References (59)

1. Anderson A.R.A. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math. Med. Biol. 22 (2005) 163-186
2. Anderson A.R.A., and Chaplain M.A.J. Continuous and discrete mathematical models of tumour-induced angiogenesis. Bull. Math. Biol. 60 (1998) 857-899
3. Anderson A.R.A., Chaplain M.A.J., Newman E.L., Steele R.J.C., and Thompson A.M. Mathematical modelling of tumour invasion and metastasis. J. Theor. Med. 2 (2000) 129-154
4. Arthur D. Accelerated partial breast irradiation: a change in treatment paradigm for early stage breast cancer. J. Surg. Oncol. 84 (2003) 185-191
5. Bannister, L.H., Berry, M.M., Collins, P., Dyson, M., Dussek, J.E., 1995. Gray's anatomy, 38th ed. Churchill Livingstone, New York, USA, pp. 417-424.
6. Berardo M.D., Allred D.C., and O'Connel P. Breast cancer. In: Jameson J.L. (Ed). Principles of Molecular Medicine (1998), Human Press, Totowa, NJ 625-632
7. Booth, J.T., 2002. Modelling the impact of treatment uncertainties in radiotherapy. Ph.D. Thesis, University of Adelaide.
8. Bray D. Cell Movements (1992), Garland Publishing, New York
9. Brenner D.J., Armour E., Corry P., and Hall E. Sublethal damage repair times for a late-responding tissue relevant to brachytherapy (and external-beam radiotherapy): implications for new brachytherapy protocols. Int. J. Radiat. Oncol. Biol. Phys. 41 1 (1998) 135-138
10. Colley-Durel S., Guitton N., Nourgalieva K., Leveque J., Danic B., and Chenal C. Genomic instability and breast cancer. Oncol. Rep. 8 (2001) 1001-1005
11. Dairkee S.H. Allelic loss in normal lobules adjacent to breast cancer. Cancer Detect. Prevent. 22 1 (1998) 135A
12. Dale R.G. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br. J. Radiol. 58 (1985) 515-528
13. Dale R.G. Time-dependent tumour repopulation factors in linear-quadratic equations-implications for treatment strategies. Radiother. Oncol. 15 (1989) 371-381
14. Dale R.G. Dose-rate effects in targeted radiotherapy. Phys. Med. Biol. 41 (1996) 1871-1884
15. Demicheli R., Miceli R., Brambilla C., Ferrari L., Moliterni A., Zambetti M., Valagussa P., and Bonadonna G. Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'. Breast Cancer Res. Treat. 53 3 (1999) 209-215
16. Deng G., Lu Y., Zlotnikov G., Thor A.D., and Smith H.S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274 (1996) 2057-2059
17. Durante M., Grossi G.F., and Yang T.C. Radiation-induced chromosomal instability in human mammary epithelial cells. Adv. Space Res. 18 (1996) 99-108
18. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355 (2000) 1757-1770
19. Ebert M.A., and Carruthers B. Dosimetric characteristics of a low-kV intra-operative X-ray source: Implications for use in a clinical trial for treatment of low-risk breast cancer. Med. Phys. 30 9 (2003) 2424-2431
20. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., Jeong J.-H., and Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. 347 16 (2002) 1233-1241
21. Försti A., Louhelainen J., Söderberg M., Wijkström H., and Hemminki K. Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. Eur. J. Cancer 37 (2001) 1372-1380
22. Fritz P., Cabrera C.M., Dippon J., Gerteis A., Simon W., Aulitzky W.E., and van der Kuip H. c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study. Breast Cancer Res. 7 3 (2005) 374-384
23. Goldberg Z. Clinical implications of radiation-induced genomic instability. Oncogene 22 (2003) 7011-7017
24. Guerrero M., and Allen Li X. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning. Phys. Med. Biol. 48 20 (2003) 3307-3326
25. Guiot C., Degiorgis P.G., Delsanto P.P., Gabriele P., and Deisboeck T.S. Does tumor growth follow a "universal law"?. J. Theor. Biol. 225 2 (2003) 147-151
26. Herskind C., Steil V., Kraus-Tiefenbacher U., and Wenz F. Radiobiological aspects of intraoperative radiotherapy (IORT) with isotropic low-energy X-rays for early stage breast cancer. Radiat. Res. 163 2 (2005) 208-215
27. Jamieson T.A., Brizel D.M., Killian .K., Oka Y., Jang H.-S., Fu X., Clough R.W., Vollmer R.T., Anscher M.S., and Jirtle R.L. M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis. BMC Cancer 3 4 (2003)
28. Kopans D.B., Rafferty E., Georgian-Smith D., Yeh E., D'Allesandro H., Moore R., Hughes K., and Halpern E. A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena. Cancer 97 12 (2003) 2951-2959
29. Lacroix M., Toillon R.-A., and Leclercq G. Stable 'portrait'of breast tumors during progression: data from biology, pathology and genetics. Endocr.-Relat. Cancer 11 (2004) 497-522
30. Lakhani S.R., Chaggar R., Davies S., Jones C., Collins N., Odel C., Stratton M.R., and O'Hare M.J. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J. Pathol. 189 (1999) 496-503
31. Larson P.S., de las Morenas A., Bennett S.R., Adrienne Cupples L., and Rosenberg C.L. Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. Am. J. Pathol. 161 1 (2002) 283-290
32. Li Z., Moore D.H., Meng Z.H., Ljung B.M., Gray J.W., and Dairkee S.H. Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients. Cancer Res. 62 (2002) 1000-1003
33. Lorimore S.A., Coates P.J., Scobie G.E., Milne G., and Wright E.G. Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects?. Oncogene 20 (2001) 7085-7095
34. Michaelson J., Satija S., Moore R., Weber G., Halpern E., Garland A., and Kopans D.B. Estimates of breast cancer growth rate and sojourn time from screening database information. J. Women's Imag. 5 1 (2003) 11-19
35. Oldham M. Radiation physics and applications in therapeutic medicine. Phys. Educ. 36 (2001) 460-467
36. O'Neill J.S., Elton R.A., and Miller W.R. Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br. Med. J. (Clin. Res. Ed.) 296 (1988) 741-743
37. Peer P.G., van Dijck J.A., Hendriks J.H., Holland R., and Verbeek A.L. Age-dependent growth rate of primary breast cancer. Cancer 71 11 (1993) 3547-3551
38. Reitsamer R., Peintinger F., Sedlmayer F., Kopp M., Menzel C., Cimpoca W., Glueck S., Rahim H., Kopp P., Deutschmann H., Merz F., Brandis M., and Kogelnik H. Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients. Eur. J. Cancer 38 (2002) 1607-1610
39. Roychoudhuri R., Evans H., Robinson D., and Møller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br. J. Cancer 91 (2004) 868-872
40. Sachs R.K., Hahnfeld P., and Brenner D.J. The link between low-let dose-response relations and the underlying kinetics of damage production/repair/misrepair. Int. J. Biol. 72 4 (1997) 351-374
41. Sancar A., Lindsey-Boltz L.A., Ünsal-Kaçmaz K., and Linn S. Molecular Mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73 (2004) 39-85
42. Sarkaria J.N., Fowler J.F., Lindstrom M.J., Jordan V.C., and Mulcahy R.T. The decreased influence of overall treatment time on the response of human breast tumor xenografts following prolongation of the potential doubling time (Tpot). Int. J. Radiat. Oncol. Biol. Phys. 31 (1995) 833-840
43. Steinarsdottir M., Jonasson J.G., Vidarsson H., Juliusdottir H., Hauksdottir H., and Ogmundsdottir H.M. Cytogenetic changes in nonmalignant breast tissue. Genes Chrom. Cancer 41 1 (2004) 47-55
44. Tomlinson I.P.M. Mutations in normal breast tissue and breast tumours. Breast Cancer Res. 3 (2001) 299-303
45. Tozeren A., Coward C.W., and Petushi S.P. Origins and evolution of cell phenotypes in breast tumors. J. Theor. Biol. 233 (2005) 43-54
46. Trott K.R. Non-targeted radiation effects in radiotherapy-roles of radiation-induced genomic instability and of the bystander effect in cancer cure by radiotherapy. Acta Oncol. 40 (2001) 976-980
47. Turesson I., Carlsson J., Brahme A., Glimelius B., Zackrisson B., and Stenerlöw B. Biological response to radiation therapy. Acta Oncol. 42 2 (2003) 92-106
48. Utada Y., Emi M., Yoshimoto M., Kasumi F., Akiyama F., Sakamoto G., Haga S., Kajiwara T., and Nakamura Y. Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer. Clin. Cancer Res. 6 (2000) 3193-3198
49. Vaidya, J.S., 2002. A novel approach to local treatment of breast cancer. Ph.D. Thesis, University College London.
50. Vaidya J.S., Baum M., Tobias J.S., and Houghton J. Randomised trials are not unethical (Letter). Lancet 535 (1999) 1714
51. Vaidya J.S., Vyas J.J., Chinoy R.F., Merchant N., Sharma O.P., and Mittra I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br. J. Cancer 74 (1996) 820-824
52. Vaidya J.S., Baum M., Tobias J.S., D'Souza D.P., Naidu S.V., Morgan S., Metaxas M., Harte K.J., Sliski A.P., and Thomson E. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann. Oncol. 12 (2001) 1075-1080
53. Vaidya J.S., Baum M., Tobias J.S., Morgan S., and D'Souza D.P. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. EJSO 28 (2002) 447-454
54. Vaidya J.S., Tobias J.S., Baum M., Keshtgar M., Joseph D., Wenz F., Houghton J., Saunders C., Corica T., D'Souza D.P., Sainsbury R., Massarut S., Taylor I., and Hilaris B. Intraoperative radiotherapy for breast cancer. Lancet Oncol. 5 (2004) 165-173
55. Vaidya J.S., Tobias J.S., Baum M., Wenz F., Kraus-Tiefenbacher U., D'Souza D.P., Keshtgar M., Massarut S., Hilaris B., Saunders C., and Joseph D. TARGeted Intraoperative radioTherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin. Radiat. Oncol. 15 (2005) 84-91
56. Veronesi U., Orecchia R., Luini A., Gatti G., Intra M., Zurrida S., Ivaldi G., Tosi G., Ciocca M., Tosoni A., and De Lucia F. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur. J. Cancer 37 (2001) 2178-2183
57. Wyatt R.M., Beddoe A.H., and Dale R.G. The effects of delays in radiotherapy treatment on tumour control. Phys. Med. Biol. 48 (2003) 139-155
58. Yang T.C., Stampfer M.R., and Tobias C.A. Radiation studies on sensitivity and repair of human mammary epithelial cells. Int. J. Radiat. Biol. 56 (1989) 605-609
59. Yarnold J., Ashton A., Bliss J., Homewood J., Harper C., Hanson J., Haviland J., Bentzen S., and Owen B. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother. Oncol. 75 (2005) 9-17